摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl (S)-N-iso-propyl-2-amino-3-methylbutanoate | 219639-09-5

中文名称
——
中文别名
——
英文名称
methyl (S)-N-iso-propyl-2-amino-3-methylbutanoate
英文别名
N-isopropyl-L-valine methyl ester;methyl (2S)-3-methyl-2-(propan-2-ylamino)butanoate
methyl (S)-N-iso-propyl-2-amino-3-methylbutanoate化学式
CAS
219639-09-5
化学式
C9H19NO2
mdl
——
分子量
173.255
InChiKey
UKCDSLLDLDNZNK-QMMMGPOBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    206.4±23.0 °C(Predicted)
  • 密度:
    0.909±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    12
  • 可旋转键数:
    5
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    38.3
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl (S)-N-iso-propyl-2-amino-3-methylbutanoate 在 lithium aluminium tetrahydride 、 乙酸酐 作用下, 以 四氢呋喃 为溶剂, 反应 3.0h, 生成 (S)-N-formyl-N-iso-propyl-2-amino-3-methyl-1-butanol
    参考文献:
    名称:
    Investigation of the importance of nitrogen substituents in a N–P chiral ligand for enantioselective allylic alkylation
    摘要:
    The synthesis of three chiral chelate nitrogen-phosphorus (S)-valine derived ligands with the potential fur stereogenic nitrogen donation is described. In palladium catalysed allylic substitution reactions the ligands induced varying enantioselectivities ranging From 92%, e.e. of the (R)-enantiomer to 83% e.e. of the (S)-enantiomer. Structural and spectroscopic investigations into the origin of this effect were conducted, but were inconclusive. However, the importance of the consideration of N-substituents in such systems is highlighted. (C) 2001 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0957-4166(01)00137-9
  • 作为产物:
    参考文献:
    名称:
    钽酰氨基醇盐配合物对氨基丙二烯的不对称催化分子内加氢胺化
    摘要:
    制备了一系列手性双齿氨基烷氧化物配体的钽配合物。得到一种配合物Ta(NMe 2)3 [-OCPh 2 CH(CHMe 2)N(c -C 6 H 11)-]的晶体结构。不同于先前描述的具有这些配体的钛配合物,它们与桥连的氧原子二聚,该钽配合物是具有近似三角-双锥体几何结构的单体。检查所得复合物的原位活性用于氨基丙烯的不对称催化氨化/环化反应。在135℃下以5 mol%的催化剂负载量,将6-甲基庚-4,5-二烯基胺环化为2-(2-甲基丙烯基)吡咯烷,观察到高达80%ee的对映选择性。
    DOI:
    10.1021/om200446v
点击查看最新优质反应信息

文献信息

  • Copper-Catalyzed Rearrangement of Tertiary Amines through Oxidation of Aliphatic CH Bonds in Air or Oxygen: Direct Synthesis of α-Amino Acetals
    作者:Jie-Sheng Tian、Teck-Peng Loh
    DOI:10.1002/anie.201003646
    日期:2010.11.2
    A surprising turn of events: Mechanistic studies, including trapping, control, and isotope‐labeling experiments, led to the proposal of a rearrangement mechanism involving oxidation of aliphatic CH bonds (see scheme; TMEDA=tetramethylethylenediamine).
    令人惊讶的事件转折:机理研究,包括捕集,控制和同位素标记实验,导致提出了涉及脂族CH键氧化的重排机制的提议(参见方案; TMEDA =四甲基乙二胺)。
  • CARBOCYCLIC OXIME HEPATITIS C VIRUS SERINE PROTEASE INHIBITORS
    申请人:Liu Dong
    公开号:US20090149491A1
    公开(公告)日:2009-06-11
    The present invention discloses compounds of formula I, II, or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. More specifically, the invention relates to oxime compounds containing a carbocyclic P2 unit. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
    本发明揭示了化合物I、II的结构,或其药用可接受的盐、酯或前药:这些化合物抑制丝氨酸蛋白酶活性,特别是乙型肝炎病毒(HCV)NS3-NS4A蛋白酶的活性。因此,本发明的化合物干扰了乙型肝炎病毒的生命周期,并且还可用作抗病毒剂。更具体地,本发明涉及含有环戊二烯基P2单元的肟化合物。本发明还涉及包括上述化合物的药物组合物,用于给患有HCV感染的受试者。该发明还涉及通过给予含有本发明化合物的药物组合物来治疗受试者的HCV感染的方法。
  • Concepts for ligand design in asymmetric catalysis: a study of chiral amino thiol ligands
    作者:James C. Anderson、Rachel Cubbon、Michael Harding、Daniel S. James
    DOI:10.1016/s0957-4166(98)00344-9
    日期:1998.10
    A series of new chiral sulfur-nitrogen chelate ligands, derived from amino acids, has been synthesised rationally. Fruitless experiments into catalytic asymmetric conjugate additions and desymmetrisation of meso-epoxides led us to analyse our ligands in the catalytic asymmetric addition of diethylzinc to aromatic aldehydes. These latter experiments were successful with chiral benzylic alcohols being obtained in up to 82% enantiomeric excess. (C) 1998 Elsevier Science Ltd. All rights reserved.
  • Sterically encumbered chiral amino alcohols for titanium-catalyzed asymmetric intramolecular hydroamination of aminoallenes
    作者:Amanda J. Hickman、Lauren D. Hughs、Casey M. Jones、Hanhan Li、Joanne E. Redford、Samuel J. Sobelman、J. Andrew Kouzelos、Adam. R. Johnson
    DOI:10.1016/j.tetasy.2009.04.013
    日期:2009.6
    A variety of sterically encumbered amino alcohol ligands were prepared in a two-step modular synthesis. The titanium complexes of these ligands were prepared in situ and used as catalysts for hydroamination. The intramolecular hydroamination of 6-methyl-hepta-4,5-dienylamine at 135 degrees C with 5 mol % catalyst gave exclusively 2-(2-methyl-propenyl)-pyrrolidine with enantiomeric excesses up to 16%. (C) 2009 Elsevier Ltd. All rights reserved.
  • US8426360B2
    申请人:——
    公开号:US8426360B2
    公开(公告)日:2013-04-23
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物